Cavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SA

In This Article:

Cavitation Technologies, Inc
Cavitation Technologies, Inc

CHATSWORTH, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB: CVAT), a leading ESG company designing and manufacturing innovative flow-through nano-technology systems for fluid processing applications worldwide, provides a corporate update and letter to shareholders.

Dear Shareholders,

Our fiscal year, ending on June 30, 2024, has been challenging, but it has allowed the company to clearly define both near- and long-term strategies, develop new technologies, and position us to pursue multiple opportunities in water treatment and remediation applications. We have also continued joint efforts with Alchemy Beverages, Inc. to monetize their alcoholic beverages and small kitchen appliance Barmuze.

In 2024, the market valuation of our company was reduced to approximately $3 million, which limited our ability to fund operations and pursue opportunities in water remediation. It is no secret that the overall Micro Cap Market has been struggling since 2023, with many companies in that space seeing significant declines in capitalization. Access to capital has been challenging due to high interest rates and limited liquidity. Nevertheless, I believe that entering Fiscal Year 2025 our company has the capability to execute the business model we have developed in recent years. Additionally, as CEO, I have consistently purchased our company stock and have not sold a single share during my entire tenure because I believe that the unique technologies we have developed over the past decade position our company for exponential growth, and I truly believe that we are greatly undervalued.

Transaction with Desmet Group, SA

Our relationship with Desmet has been invaluable for over a decade. Desmet has provided the capital necessary for our company to continue operations and develop new, unique technologies. We are very grateful to Desmet for its past collaboration and recognition of the value of our unique technology.

In 2024, we are at a crossroads: either substantially dilute our existing shareholders or sell some assets that are outside of what we view as our bigger opportunities going forward. Since those opportunities require additional funding, we concluded that the best route was to sell some intellectual property rights related to vegetable oil refining to Desmet.

As consideration for the patent assignments, Desmet has agreed to pay the Company in aggregate for patents and some purchased orders approximately $1.1 million (USD) in cash and forgiveness of approximately $400,000 (USD) in advances. This transaction will provide the necessary capital for continuous operations and business development of our company while avoiding toxic financing.